Viewing Study NCT04747795



Ignite Creation Date: 2024-05-06 @ 3:45 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04747795
Status: COMPLETED
Last Update Posted: 2024-01-25
First Post: 2021-02-04

Brief Title: Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments
Sponsor: Universitaire Ziekenhuizen KU Leuven
Organization: Universitaire Ziekenhuizen KU Leuven

Study Overview

Official Title: Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments a Multicentre Double Blinded Randomized Controlled Trial the C-EASIE Trial
Status: COMPLETED
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: c-easie
Brief Summary: In this clinical trial the effect of early administration of Vitamin C is investigated in patients admitted at the emergency department with sepsis or septic shock

When a patient has sepsis hisher body is causing damage to its own tissues and organs as result of an infection This can lead to septic shock The patient has a low blood pressure hisher organs stop working and the patient may even die

The aim of this trial is to investigate the efficiency of Vitamin C in sepsis and septic shock Vitamin C is a vitamin present in various foods and has been approved as dietary supplement by the Belgian authorities Over the years it has been proven that Vitamin C is very safe In addition several studies have shown that Vitamin C can also have a protective effect It can reduce organ damage and increase survival rates Although several studies suggest that Vitamin C can help fight sepsis it is not yet used in practice This Belgian trial in which several hospitals participate hopes to provide a clear answer to the question Should Vitamin C be administered to patients admitted in an emergency department with sepsis or septic shock
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2020-001862-12 EUDRACT_NUMBER None None
KCE 19-1237 OTHER_GRANT Federaal kenniscentrum voor de gezondheidszorg KCE None